Technical Report No. 73-2: Application of Medical Device Regulation Annex 1 Requirements for Staked Needle Syringes

Published
Feb 2024
ISBN
978-1-945584-44-2
Pages
41
PDA Item Number
43570

Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.

Format
PDF Single User
Member Price
$180.00
Nonmember Price
$325.00
Government Price
$180.00

PDA Technical Report No. 73-2: Application of Medical Device Regulations, Annex I Requirements for Staked Needle Syringes represents the current state of knowledge as to the application of European Union Regulation (EU) 2017/745 on medical devices (MDR).

Since this regulatory requirement is new, expectations of the Notified Body and competent authorities may diverge as the process evolves. As an addendum to PDA Technical Report No. 73: Prefilled Syringe User Requirements for Biotechnology Applications, this technical report provides recommendations on preparing the required documentation of the device part of the PFS to facilitate obtaining an opinion.

This technical report systematically recommends the amount and depth of information needed for each relevant GSPR to support pharmaceutical companies in assembling the submission file to the NBs and provides information on documents that provide guidance on completing the NB submission file.

The device part, including its corresponding componentsandmaterials, are in scope as they will be evaluated by the NBs, but the medicinal product (drug) is not.

Table of Contents

 

1.0. Introduction

2.0. Glossary and Abbreviations

3.0. Regulatory Background

4.0. Content of Submission file to notified bodies  

5.0. Applicable GSPRS and Supportive Documents

6.0. References

About the Authors

Fabrizio Bacelle, Stevanato Group

Bettine Boltres, PhD, West Pharmaceutical Services

Alfred Breunig, Nipro PharmaPackaging International

Rakhi Dalal, PhD., U.S. Food and Drug Administration

Wendy Durand, PharmD, Aptar Pharma

Andreas Emmendoerffer, MD, PhD, F. Hoffmann-La Roche Ltd.

Stephanie Goebel, Novartis

Elly Gysels, PhD, Sensile Medical AG

Tibor Hlobik, West Pharmaceutical Services Inc.

Vikas Jaitely, PhD, Merck Group

Ankica Jakovljevic, PharmD, Stevanato Group

Mayk Kresse, PhD, Bayer Pharma AG

Andrea Salmaso, PharmD, Stevanato Group

Tabassam Sharif, Datwyler Pharma Packaging

Gabriele Widerstein, Boehringer Ingelheim

Urs Widmer, confinis AG

Daniele Zuccato, SCHOTT Pharma

Chris Hurlstone, Team Consulting Ltd.

Mark Di Cioccio, Team Consulting Ltd.

Alastair Willoughby, Team Consulting Ltd.

Larry Wallman, Genentech

Desmon Dizon, Genentech

Christoph Joosten, PhD, F. Hoffmann-La Roche Ltd.

Stephanie Horn, PhD, F. Hoffmann-La Roche Ltd.

Federica Rusmini, Janssen Vaccines & Prevention B.V.

Tilman Roedle and Associates., Vetter Pharma